Global Point of Care
Determine™ TB LAM Ag
Rapid Rule-in TB-HIV Co-infection
Now there is a new advantage to help detect active Tuberculosis (TB) in the HIV community. The Determine™ TB LAM Ag test empowers you, at the point-of-care, to screen for active TB in HIV positive patients, providing results in just minutes.
This rapid test detects the LAM antigen (lipoarabinomannan) in urine samples, assisting you in your TB screening to rule-in sooner than traditional methods and enabling earlier treatment for your patient.
助益
- The Determine™ TB LAM Ag test empowers you, at the point-of-care, to screen for active TB in HIV positive patients, providing results in just minutes.
- Offers optimal performance in HIV positive patients with advanced immunosuppression.
- A useful tool for detecting sputum smear negative patients.
- Diagnose both pulmonary and extra pulmonary TB from one convenient urine sample.
- Enhanced power comes through combination with methods such sputum smear microscopy or the Xpert® MTB/RIF test.
- Uses unprocessed urine as the validated sample type.
- LAM, lipoarabinomannan, is a structurally important component of the outer cell wall of mycobacteria that is shed from metabolically active or degrading cells, is cleared by the kidney and detectable in urine.
- Results in 25 minutes.
詳細資訊
說明文件
產品規格
Product Information
Method | Lateral flow |
Performance
Specificity1 | > 98% |
品項
| Determine™ TB LAM Ag | Code |
|---|---|
| Determine™ TB LAM Ag 25 tests | 7D2741 |
For Australia prefix code with DT